Assignee
ARDEA BIOSCIENCES INC
US·27 granted patents·31 pending applications·254 citations·filing 2005–2022
Top patents by PatentIndex Score
58 records- 0198US7683087B2N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl] -p-amino benzoic acids as HIV reverse transcriptase inhibitorsARDEA BIOSCIENCES INC·Filed 2008·Granted Mar 23, 2010·34 cites·36 claims
- 0298US7435752B2N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benozioc acids as HIV reverse transcriptase inhibitorsARDEA BIOSCIENCES INC·Filed 2005·Granted Oct 14, 2008·50 cites·19 claims
- 0396US8003681B22-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and methyl esterARDEA BIOSCIENCES INC·Filed 2009·Granted Aug 23, 2011·31 cites·2 claims
- 0495US7820664B2Inhibitors of MEKARDEA BIOSCIENCES INC·Filed 2008·Granted Oct 26, 2010·37 cites·59 claims
- 0594US8541589B2Thioacetate compounds, compositions and methods of useARDEA BIOSCIENCES INC·Filed 2013·Granted Sep 24, 2013·8 cites·10 claims
- 0693US8044240B2Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereofARDEA BIOSCIENCES INC·Filed 2009·Granted Oct 25, 2011·24 cites·10 claims
- 0792US8759577B2Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereofARDEA BIOSCIENCES INC·Filed 2013·Granted Jun 24, 2014·19 cites·19 claims
- 0890US8357713B2Compounds and compositions and methods of useARDEA BIOSCIENCES INC·Filed 2011·Granted Jan 22, 2013·9 cites·12 claims
- 0987US8629278B2Thioacetate compounds, compositions and methods of useARDEA BIOSCIENCES INC·Filed 2013·Granted Jan 14, 2014·6 cites·8 claims
- 1087US7429667B2Phenylamino isothiazole carboxamidines as MEK inhibitorsARDEA BIOSCIENCES INC·Filed 2006·Granted Sep 30, 2008·7 cites·13 claims
- 1185US8884058B2Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamideARDEA BIOSCIENCES INC·Filed 2013·Granted Nov 11, 2014·2 cites·8 claims
- 1285US7595324B2Substituted thieno[3,2-D]pyrimidines as HIV inhibitorsARDEA BIOSCIENCES INC·Filed 2007·Granted Sep 29, 2009·7 cites·18 claims
- 1383US7652047B2Phenylamino isothiazole carboxamidines as MEK inhibitorsARDEA BIOSCIENCES INC·Filed 2008·Granted Jan 26, 2010·4 cites·27 claims
- 1482US8372807B2Methods of modulating uric acid levelsARDEA BIOSCIENCES INC·Filed 2010·Granted Feb 12, 2013·8 cites·15 claims
- 1580US8344012B2Compounds, compositions and methods of using same for modulating uric acid levelsARDEA BIOSCIENCES INC·Filed 2009·Granted Jan 1, 2013·3 cites·13 claims
- 1675US10047050B23,4-di-substituted pyridine compound, methods of using and compositions comprising the sameARDEA BIOSCIENCES INC·Filed 2012·Granted Aug 14, 2018·2 cites·13 claims
- 1775US9956205B2Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereofARDEA BIOSCIENCES INC·Filed 2016·Granted May 1, 2018·1 cites·12 claims
- 1872US2021171466A1Thioacetate compounds, compositions and methods of useARDEA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1970US10919858B2Thioacetate compounds, compositions and methods of useARDEA BIOSCIENCES INC·Filed 2018·Granted Feb 16, 2021·0 cites·13 claims
- 2070US9296709B2Manufacture of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acidARDEA BIOSCIENCES INC·Filed 2013·Granted Mar 29, 2016·1 cites·9 claims
- 2169US10772886B2CXCR-2 inhibitors for treating crystal arthropathy disordersARDEA BIOSCIENCES INC·Filed 2017·Granted Sep 15, 2020·1 cites·11 claims
- 2269US2023011269A1Pharmaceutical composition comprising a potent inhibitor of urat1ARDEA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2368US9296686B2Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamideARDEA BIOSCIENCES INC·Filed 2014·Granted Mar 29, 2016·0 cites·8 claims
- 2468US2019142805A1Novel Compounds and Compositions and Methods of UseARDEA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 2566US2008249131A1Non-nucleoside reverse transcriptase inhibitorsARDEA BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 2666US2015094284A1S-triazolyl alpha-mercapto acetanilides as inhibitors of hiv reverse transcriptaseARDEA BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 2765US10183012B2Compounds and compositions and methods of useARDEA BIOSCIENCES INC·Filed 2016·Granted Jan 22, 2019·0 cites·21 claims
- 2864US9174933B2Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereofARDEA BIOSCIENCES INC·Filed 2014·Granted Nov 3, 2015·0 cites·12 claims
- 2964US2019111028A1Polymorphic Forms of 2-(5-Bromo-4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-Triazol-3-ylthio)Acetic Acid and Uses ThereofARDEA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 3064US2015105410A1Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereofARDEA BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 3163US2014005136A1Novel compounds and compositions and methods of useARDEA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 3262US2018235939A1Polymorphic Forms of 2-(5-Bromo-4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-Triazol-3-ylthio)Acetic Acid and Uses ThereofARDEA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 3362US2018002296A1S-triazolyl alpha-mercapto acetanilides as inhibitors of hiv reverse transcriptaseARDEA BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 3462US2011244049A1Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof, and methods for preparing and using sameARDEA BIOSCIENCES INC·Filed 2009·Application pending·0 cites
- 3561US2013331403A1Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereofARDEA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 3661US2021113472A1Pharmaceutical composition comprising a potent inhibitor of urat1ARDEA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3760US2016221970A1Novel compounds and compositions and methods of useARDEA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 3860US2008249066A1Antiviral compounds and compositionsARDEA BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 3959US2014128338A1Compounds, compositions and methods of using same for modulating uric acid levelsARDEA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 4058US10570095B23,4-di-substituted pyridine compound, methods of using and compositions comprising the sameARDEA BIOSCIENCES INC·Filed 2018·Granted Feb 25, 2020·0 cites·20 claims
- 4158US2018161314A1Methods for Treating Hyperuricemia and Related DiseasesARDEA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 4258US2016221969A1Compounds, compositions and methods of using same for modulating uric acid levelsARDEA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 4355US2020281878A1Cxcr-2 inhibitors for treating disordersARDEA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 4455US2019015392A1Treatment of Gout and HyperuricemiaARDEA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 4554US2013040963A1Compounds, Compositions and Methods of Using Same for Modulating Uric Acid LevelsARDEA BIOSCIENCES INC·Filed 2012·Application pending·0 cites
- 4654US2017183333A1Derivatives of n-(arylamino) sulfonamides as inhibitors of mekARDEA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 4750US9220696B2Pharmaceutical combinations for treatment of specific cancersARDEA BIOSCIENCES INC·Filed 2013·Granted Dec 29, 2015·0 cites·19 claims
- 4850US8354532B2Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIVARDEA BIOSCIENCES INC·Filed 2012·Granted Jan 15, 2013·0 cites·14 claims
- 4949US2011269741A1Novel compositions and methods of useARDEA BIOSCIENCES INC·Filed 2011·Application pending·0 cites
- 5049US2013345271A1Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetate, and uses thereofARDEA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ARDEA BIOSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →